Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity

HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively diversified HIV-1 envelope glycoproteins (Env) rapidly acquire mutations to evade individual bNAbs in monotherapy regimens. The use of a “single” a...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinhardt, James J., Guenaga, Javier, Turner, Hannah L., McKee, Krisha, Louder, Mark K., O’Dell, Sijy, Chiang, Chi-I, Lei, Lin, Galkin, Andrey, Andrianov, Alexander K., A. Doria-Rose, Nicole, Bailer, Robert T., Ward, Andrew B., Mascola, John R., Li, Yuxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830440/
https://www.ncbi.nlm.nih.gov/pubmed/29491415
http://dx.doi.org/10.1038/s41467-018-03335-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830440/
https://www.ncbi.nlm.nih.gov/pubmed/29491415
http://dx.doi.org/10.1038/s41467-018-03335-4

Ejemplares similares